{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:16:07Z","timestamp":1790374567296,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Iberoamericana de Micolog\u00eda"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.riam.2018.07.001","type":"journal-article","created":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T07:49:52Z","timestamp":1544687392000},"page":"210-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Aspergilosis invasiva en el paciente cr\u00edtico"],"prefix":"10.1016","volume":"35","author":[{"given":"Paula","family":"Ram\u00edrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Garnacho-Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.riam.2018.07.001_bib0310","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s10096-011-1365-0","article-title":"Prospective study in critically ill non-neutropenic patients: Diagnostic potential of (1,3)-\u03b2-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease","volume":"31","author":"Acosta","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"10.1016\/j.riam.2018.07.001_bib0315","first-page":"149","article-title":"Respiratory infections caused by Aspergillus spp. in critically ill patients admitted to the intensive care units","volume":"5","author":"Alvarez Lerma","year":"2014","journal-title":"Med Intensiva."},{"key":"10.1016\/j.riam.2018.07.001_bib0320","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2334-13-29","article-title":"Aspergillosis in Intensive Care Unit (ICU) patients: Epidemiology and economic outcomes","volume":"13","author":"Baddley","year":"2013","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.riam.2018.07.001_bib0325","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/1471-2334-12-295","article-title":"Repeated Aspergillus isolation in respiratory samples from non-immunocompromised patients not selected based on clinical diagnoses: Colonisation or infection?","volume":"12","author":"Barberan","year":"2012","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.riam.2018.07.001_bib0330","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12879-016-2143-5","article-title":"Development of aspergillosis in a cohort of non-neutropenic, non-transplant patients colonised by Aspergillus spp","volume":"17","author":"Barberan","year":"2017","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.riam.2018.07.001_bib0335","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2011-04-351601","article-title":"The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies","volume":"119","author":"Bergeron","year":"2012","journal-title":"Blood."},{"key":"10.1016\/j.riam.2018.07.001_bib0340","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.riam.2018.07.001_bib0345","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1128\/JCM.43.5.2075-2079.2005","article-title":"Workload due to Aspergillus fumigatus and significance of the organism in the microbiology laboratory of a general hospital","volume":"43","author":"Bouza","year":"2005","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.riam.2018.07.001_bib0350","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1183\/09031936.00062206","article-title":"Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease","volume":"30","author":"Bulpa","year":"2007","journal-title":"Eur Respir J."},{"key":"10.1016\/j.riam.2018.07.001_bib0355","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s00134-011-2344-8","article-title":"Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosis","volume":"37","author":"Burghi","year":"2011","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.riam.2018.07.001_bib0360","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1093\/jac\/dkw323","article-title":"PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay\u00ae in 201 patients with haematological disease suspected for invasive aspergillosis","volume":"71","author":"Chong","year":"2016","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.riam.2018.07.001_bib0365","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1111\/j.1439-0507.2010.01947.x","article-title":"Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC\/MSG 2008 definitions of invasive mould disease","volume":"54","author":"Cornely","year":"2011","journal-title":"Mycoses."},{"key":"10.1016\/j.riam.2018.07.001_bib0370","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","article-title":"Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)","volume":"44","author":"Cornely","year":"2007","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.riam.2018.07.001_bib0375","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/505870","article-title":"Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: A 6-year survey","volume":"43","author":"Cornillet","year":"2006","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.riam.2018.07.001_bib0380","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.riam.2018.07.001_bib0385","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/cc8925","article-title":"Clinical review: What is the role for autopsy in the ICU?","volume":"14","author":"De Vlieger","year":"2010","journal-title":"Crit Care."},{"key":"10.1016\/j.riam.2018.07.001_bib0390","doi-asserted-by":"crossref","first-page":"e42736","DOI":"10.1371\/journal.pone.0042736","article-title":"Detection of urinary excreted fungal galactomannan-like antigens for diagnosis of invasive aspergillosis","volume":"7","author":"Dufresne","year":"2012","journal-title":"PLoS ONE."},{"key":"10.1016\/j.riam.2018.07.001_bib0395","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1128\/AAC.02487-12","article-title":"Is azole resistance in Aspergillus fumigatus a problem in Spain?","volume":"57","author":"Escribano","year":"2013","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.riam.2018.07.001_bib0400","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/jac\/dkv177","article-title":"High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients","volume":"70","author":"Fuhren","year":"2015","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.riam.2018.07.001_bib0405","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.ijid.2011.10.004","article-title":"The role of combination antifungal therapy in the treatment of invasive aspergillosis: A systematic review","volume":"16","author":"Garbati","year":"2012","journal-title":"Int J Infect Dis."},{"key":"10.1016\/j.riam.2018.07.001_bib0410","article-title":"Clinical practice guideline for the management of invasive diseases caused by Aspergillus: 2017 Update by the GEMICOMED-SEIMC\/REIPI","author":"Garcia-Vidal","year":"2018","journal-title":"Enf Infecci Microb Clin."},{"key":"10.1016\/j.riam.2018.07.001_bib0415","doi-asserted-by":"crossref","first-page":"R191","DOI":"10.1186\/cc3488","article-title":"Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: Risk factors, clinical presentation and outcome","volume":"9","author":"Garnacho-Montero","year":"2005","journal-title":"Crit Care."},{"key":"10.1016\/j.riam.2018.07.001_bib0420","first-page":"173","article-title":"Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient","volume":"26","author":"Garnacho-Montero","year":"2013","journal-title":"Rev Esp Quimioter."},{"key":"10.1016\/j.riam.2018.07.001_bib0425","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1086\/430602","article-title":"Risk factors for invasive aspergillosis in solid-organ transplant recipients: A case-control study","volume":"41","author":"Gavalda","year":"2005","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.riam.2018.07.001_bib0430","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1471-2334-11-163","article-title":"Five-years surveillance of invasive aspergillosis in a university hospital","volume":"11","author":"Graf","year":"2011","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.riam.2018.07.001_bib0435","doi-asserted-by":"crossref","DOI":"10.1186\/cc9402","article-title":"Clinical features of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic obstructive respiratory diseases: A prospective study","volume":"15","author":"He","year":"2011","journal-title":"Crit Care."},{"key":"10.1016\/j.riam.2018.07.001_bib0440","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12281-017-0275-8","article-title":"Lateral flow assays for the diagnosis of invasive aspergillosis: Current status","volume":"11","author":"Heldt","year":"2017","journal-title":"Curr Fungal Infect Rep."},{"key":"10.1016\/j.riam.2018.07.001_bib0445","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med."},{"key":"10.1016\/j.riam.2018.07.001_bib0450","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1128\/AAC.00251-13","article-title":"Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies","volume":"57","author":"Hoenigl","year":"2013","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.riam.2018.07.001_bib0455","doi-asserted-by":"crossref","unstructured":"Huang L, He H, Ding Y, Jin J, Zhan Q. Values of radiological examinations for the diagnosis and prognosis of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary diseases. Clin Respir J. 2018;12:499-509. https:\/\/doi.org\/10.1111\/crj.12551.","DOI":"10.1111\/crj.12551"},{"key":"10.1016\/j.riam.2018.07.001_bib0460","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12879-017-2307-y","article-title":"Is Bulpa criteria suitable for the diagnosis of probable invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease? A comparative study with EORTC\/MSG and ICU criteria","volume":"17","author":"Huang","year":"2017","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.riam.2018.07.001_bib0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2016.01.027","article-title":"Aspergillus PCR in serum for the diagnosis, follow-up and prognosis of invasive aspergillosis in neutropenic and nonneutropenic patients","volume":"22","author":"Imbert","year":"2016","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.riam.2018.07.001_bib0470","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/QCO.0000000000000043","article-title":"Approach to invasive pulmonary aspergillosis in critically ill patients","volume":"27","author":"Koulenti","year":"2014","journal-title":"Curr Opin Infect Dis."},{"key":"10.1016\/j.riam.2018.07.001_bib0475","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00134-010-1962-x","article-title":"Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock","volume":"36","author":"Landelle","year":"2010","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.riam.2018.07.001_bib0480","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jinf.2014.04.010","article-title":"Aspergillus in the lower respiratory tract of immunocompetent critically ill patients","volume":"69","author":"Lugosi","year":"2014","journal-title":"J Infect."},{"issue":"10020","key":"10.1016\/j.riam.2018.07.001_bib0485","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): A phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.riam.2018.07.001_bib0490","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M13-2508","article-title":"Combination antifungal therapy for invasive aspergillosis: a randomized trial","volume":"162","author":"Marr","year":"2015","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.riam.2018.07.001_bib0495","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00134-016-4578-y","article-title":"Increased incidence of co-infection in critically ill patients with influenza","volume":"43","author":"Mart\u00edn-Loeches","year":"2017","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.riam.2018.07.001_bib0500","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","article-title":"Galactomannan in bronchoalveolar lavage fluid: A tool for diagnosing aspergillosis in intensive care unit patients","volume":"177","author":"Meersseman","year":"2008","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.riam.2018.07.001_bib0505","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1128\/JCM.01655-16","article-title":"Application of mass spectrometry technology to early diagnosis of invasive fungal infections","volume":"54","author":"Mery","year":"2016","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.riam.2018.07.001_bib0510","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/cid\/civ571","article-title":"Isavuconazole: A new broad-spectrum triazole antifungal agent","volume":"61","author":"Miceli","year":"2015","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.riam.2018.07.001_bib0515","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3109\/13693780903514872","article-title":"Influence of host immunosuppression on CT findings in invasive pulmonary aspergillosis","volume":"48","author":"Milito","year":"2010","journal-title":"Med Mycol."},{"key":"10.1016\/j.riam.2018.07.001_bib0520","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.imlet.2004.07.009","article-title":"The anti- inflammatory response dominates after septic shock: Association of low monocyte HLA-DR expression and high interleukin-10 concentration","volume":"95","author":"Monneret","year":"2004","journal-title":"Immunology Letters."},{"key":"10.1016\/j.riam.2018.07.001_bib0525","first-page":"402","article-title":"Determining the analytical specificity of PCR-based assays for the diagnosis of IA: What is Aspergillus?","volume":"55","author":"Morton","year":"2017","journal-title":"Med Mycol."},{"key":"10.1016\/j.riam.2018.07.001_bib0530","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijid.2014.07.007","article-title":"Salvage combination antifungal therapy for acute invasive aspergillosis may improve outcomes: A systematic review and meta-analysis","volume":"28","author":"Panackal","year":"2014","journal-title":"Int J Infect Dis."},{"key":"10.1016\/j.riam.2018.07.001_bib0535","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.riam.2018.07.001_bib0540","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jinf.2010.08.014","article-title":"Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis","volume":"61","author":"Park","year":"2010","journal-title":"J Infect."},{"key":"10.1016\/j.riam.2018.07.001_bib0545","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/cid\/cis599","article-title":"The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: A randomized controlled trial","volume":"55","author":"Park","year":"2012","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.riam.2018.07.001_bib0550","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.riam.2018.07.001_bib0555","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4065\/75.6.562","article-title":"Comparison of premortem clinical diagnoses in critically ill patients and subsequent autopsy findings","volume":"75","author":"Roosen","year":"2000","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.riam.2018.07.001_bib0560","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMra0808853","article-title":"Aspergillosis","volume":"360","author":"Segal","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.riam.2018.07.001_bib0565","doi-asserted-by":"crossref","first-page":"321-324","DOI":"10.1007\/s00134-002-1576-z","article-title":"Characteristics of discrepancies between clinical and autopsy diagnoses in the intensive care unit: A 5-year review","volume":"29","author":"Silfvast","year":"2003","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.riam.2018.07.001_bib0570","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1128\/JCM.00478-16","article-title":"Detection of Aspergillus fumigatus in blood samples from critically ill patients in intensive care units by use of the SeptiFast Assay","volume":"54","author":"Steinmann","year":"2016","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.riam.2018.07.001_bib0575","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13054-014-0722-7","article-title":"Epidemiology of invasive aspergillosis in critically ill patients: Clinical presentation, underlying conditions, and outcomes","volume":"19","author":"Taccone","year":"2015","journal-title":"Crit Care."},{"key":"10.1016\/j.riam.2018.07.001_bib0580","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jcrc.2017.03.025","article-title":"A prospective study of fungal biomarkers to improve management of invasive fungal diseases in a mixed specialty critical care unit","volume":"40","author":"Talento","year":"2017","journal-title":"J Crit Care."},{"key":"10.1016\/j.riam.2018.07.001_bib0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: Executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"12","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.riam.2018.07.001_bib0590","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1469-0691.12041","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: Adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)","volume":"18","author":"Ullmann","year":"2012","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.riam.2018.07.001_bib0595","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1128\/JCM.01580-16","article-title":"A new panfungal real-time PCR assay for the diagnosis of invasive fungal infections (IFIs)","volume":"54","author":"Valero","year":"2016","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.riam.2018.07.001_bib0600","doi-asserted-by":"crossref","DOI":"10.1186\/cc4823","article-title":"Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients","volume":"10","author":"Vandewoude","year":"2006","journal-title":"Crit Care."},{"key":"10.1016\/j.riam.2018.07.001_bib0605","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1128\/JCM.00345-17","article-title":"Diagnostic value of galactomannan antigen test in serum and bronchoalveolar lavage fluid samples from patients with nonneutropenic invasive pulmonary aspergillosis","volume":"55","author":"Zhou","year":"2017","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.riam.2018.07.001_bib0610","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1093\/infdis\/jiu017","article-title":"Voriconazole metabolism, toxicity, and the effect of cytochrome P450 2C19 genotype","volume":"209","author":"Zonios","year":"2014","journal-title":"J Infect Dis."}],"container-title":["Revista Iberoamericana de Micolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130140618300573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130140618300573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T20:44:07Z","timestamp":1572986647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130140618300573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1130140618300573"],"URL":"https:\/\/doi.org\/10.1016\/j.riam.2018.07.001","relation":{},"ISSN":["1130-1406"],"issn-type":[{"value":"1130-1406","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspergilosis invasiva en el paciente cr\u00edtico","name":"articletitle","label":"Article Title"},{"value":"Revista Iberoamericana de Micolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.riam.2018.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Asociaci\u00f3n Espa\u00f1ola de Micolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}